Skip to main content
Equibles

LOS ANGELES CAPITAL MANAGEMENT LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1177206 LOS ANGELES, CA
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,616,498
-$21,684 QoQ
Shares Held
137,929
-10.7% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#85
of 271 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority Sole 28% Shared 0% None 72%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,466,927 across 167 Biotechnology names. ARQT ranks #14 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 729,635 $219,642,024
2 HALO
Halozyme Therapeutics, Inc.
 1,938,035 $151,689,999
3 CAI
Caris Life Sciences, Inc.
 3,958,531 $70,541,022
4 INCY
Incyte Corp
 578,986 $65,633,852
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 130,802 $64,973,277
6 EXEL
Exelixis, Inc.
 1,159,457 $63,086,055
7 REGN
Regeneron Pharmaceuticals, Inc.
 98,585 $61,471,690
8 RPRX
Royalty Pharma plc
 877,674 $49,211,181

All Filings in ARQT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,616,498 137,929
2026-03-31 $3,638,182 154,422
2025-12-31 $1,873,167 64,503
2025-09-30 $1,188,021 63,025
2025-06-30 $432,699 30,863
2025-03-31 $482,697 30,863
2024-12-31 $428,946 30,793
2024-09-30 $1,163,457 125,103
2024-06-30 $1,264,316 135,948
2024-03-31 $1,470,971 148,433
2023-12-31 $628,109 194,461
2022-03-31 $505,709 26,257
2021-12-31 $580,242 27,977
2021-09-30 $668,203 27,970
2021-06-30 $728,370 26,690